Skip to main content
. 2016 Nov 23;7(52):87091–87099. doi: 10.18632/oncotarget.13526

Figure 2. miR-595 was downregulated in ovarian cancer tissues.

Figure 2

(A) The expression of miR-595 in the ovarian cancer tissues was determined by qRT-PCR. (B) Among these, the miR-595 expression was downregulated in the 29 ovarian cancer tissues (29/35; 74.2%) compared to the adjacent tissues. (C) miR-595 expression in the lymph node metastases tissues and the primary ovarian cancer tissues and the normal tissues was measured by qRT-PCR. *p < 0.05 and ***p < 0.001.